Bioelectronics Corp (BIEL)

[Daytime_Lantern]

With this post, I come in out of the cold for a brief moment, and thus, suspend my self imposed exile from board participation. My reason for doing so is to bring prospective regarding to cost numbers associated with BIEL's losses over the years. The losses are substantial, but they are representative of expected cost demands/losses of bringing a product like Actipatch to market; thus, so posited by the article presented below:

"The average cost to bring a low-to-moderate 510(k) product from concept to market is $31 million. High-risk PMA costs averaged $94 million, with $75 million spent on FDA-linked stages. Article: May 25, 2017"

So, there you have it! So, Auf wiedersehen, once again!


As Always, GLTA!!!